Form 4: Omada Health CFO Sells Shares Under 10b5-1 Plan

Omada Health's Chief Financial Officer, Steven L. Cook, reported transactions involving the sale and acquisition of company stock under a pre-arranged 10b5-1 trading plan.

Summary

• Steven L. Cook, Chief Financial Officer of Omada Health, Inc. (OMDA), executed several transactions involving the company's common stock.
• On July 1, 2026, Cook acquired 23,263 shares of common stock at $8.28 per share and sold 23,263 shares at a weighted average price of $22.76. This acquisition was linked to stock options.
• On July 7, 2026, Cook acquired additional shares: 10,601 at $8.28, 1,042 at $8.01, and 694 at $7.68. On the same day, he sold 12,337 shares at a weighted average price of $23.08.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on March 14, 2026.
• Following these transactions, Cook beneficially owns 197,810 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. While the sale of shares by a CFO can be a negative signal, the execution under a 10b5-1 plan mitigates concerns about insider trading and suggests a pre-determined strategy.

Positives

• The transactions were executed under a Rule 10b5-1 trading plan, indicating pre-planned and potentially non-insider trading activity.
• The acquisition of shares at lower prices ($7.68 - $8.28) and subsequent sales at higher prices ($22.11 - $23.30) suggest a profitable execution of the plan.

Negatives

• A significant number of shares were sold by a key executive, which could be perceived negatively by the market.
• The weighted average sale prices ($22.76 and $23.08) are considerably higher than the acquisition prices for the associated stock options ($8.28, $8.01, $7.68).

Risks

• The sale of a substantial number of shares by the CFO could signal a lack of confidence in future stock performance, although it was executed under a pre-arranged plan.
• The weighted average sale prices reflect the market value at the time of the transactions, and future market performance is uncertain.

Future Outlook

The filing itself does not contain forward-looking statements or guidance. The transactions are based on a pre-established trading plan.

Management Comments

• Transactions were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.
• The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected for transactions executed in multiple trades.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for public company executives and directors. The use of a 10b5-1 plan is a common strategy to diversify holdings or raise liquidity without triggering insider trading concerns, provided the plan is established when the executive does not possess material non-public information.

Stakeholder Impact

• Shareholders may interpret the CFO's stock sales as a potential negative signal, despite the 10b5-1 plan, which could influence short-term stock price movement.
• Employees with stock options may note the exercise and sale prices, potentially impacting their own option strategies.
• Creditors and suppliers are unlikely to be directly impacted by this type of filing.

Next Steps

• Continued adherence to the 10b5-1 trading plan, if applicable.
• Future filings on Form 4 for any further changes in beneficial ownership.

Key Dates

Recommendation

The filing reports routine stock transactions by an executive under a pre-established 10b5-1 plan. While the sale of shares by a CFO can be a concern, the structured nature of the plan suggests it's not necessarily a reflection of negative non-public information. Therefore, a 'hold' recommendation is appropriate, pending further fundamental analysis of Omada Health's business performance and outlook.

Keywords

Omada Health, OMDA, Form 4, Insider Trading, Stock Sale, Stock Option, 10b5-1 Plan, Steven L. Cook, Chief Financial Officer, Beneficial Ownership